Tag Archives: NVAX

Monday’s Highlights at Noon: Inovio Pharmaceuticals (INO), Novavax (NVAX), Wynn Resorts (WYNN), Herbalife (HLF), Arrowhead Pharmaceuticals (ARWR)

So far Monday, July 13, NASDAQ is up 1.58% and the S&P is up 2.12%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Inovio Pharmaceuticals (INO – Research Report), Novavax (NVAX – Research

Novavax (NVAX) was Downgraded to a Hold Rating at Ladenburg Thalmann & Co.

Novavax (NVAX – Research Report) received a Hold rating and a $105.00 price target from Ladenburg Thalmann & Co. analyst Michael Higgins today. The company’s shares closed last Tuesday at $104.56, close to its 52-week high of $111.77. According to

Wednesday’s Highlights at Noon: Groupon (GRPN), Novavax (NVAX), Chesapeake Energy (CHK), SunPower (SPWR), Goodrich Petroleum (GDP)

So far Wednesday, June 17, NASDAQ is up 1.46% and the S&P is down -0.47%. Here are this morning’s most active stocks: Groupon (GRPN – Research Report), Novavax (NVAX – Research Report), Chesapeake Energy (CHK – Research Report), SunPower (SPWR

The SVP & GC of Novavax is Exercising Options

Today it was reported that the SVP & GC of Novavax (NVAX – Research Report), John Herrmann, exercised options to sell 12,961 NVAX shares at $26.18 a share, for a total transaction value of $640.8K. Following John Herrmann’s last NVAX

Analysts’ Top Healthcare Picks: Novavax (NVAX), Halozyme (HALO)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Novavax (NVAX – Research Report), Halozyme (HALO – Research Report) and Bluebird Bio (BLUE – Research Report) with bullish sentiments. Novavax (NVAX)

H.C. Wainwright Reaffirms Their Buy Rating on Novavax (NVAX)

H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Novavax (NVAX – Research Report) on April 30 and set a price target of $33.00. The company’s shares closed last Friday at $17.33. According to TipRanks.com, Bernardino is a 5-star